Background: Kidneys as vital organs remove waste material from blood. Additionally, they may also have a role in the electrolyte balance, regulation of blood pressure, and red blood cell genesis. Kidney diseases may be caused by several factors such as ischemia/reperfusion injury, diabetes, and nephrotoxic agents. Oxidative stress and inflammation are involved in the pathogenesis and progression of kidney diseases. Traditionally, natural antioxidants are used for treatment of renal failure in various countries. Summary: People usually select natural antioxidants since they have an opinion that herbal medicine has not any important side effects. Nigella sativa is a flavoring herb that is widely used as a condiment and as a remedy for many disorders. Thymoquinone (TQ), the most important component of black seeds, mainly oil, is considered as an active agent responsible for a lot of the seed’s useful effects. This review describes the protective roles and related mechanisms of TQ against renal disorders. The search terms, including TQ, antioxidant, renal ischemia-reperfusion, diabetic nephropathy, and nephrotoxic agent were searched in scientific databases. TQ showed anti-inflammatory and antioxidant properties in animal and in vitro models of several renal diseases caused by inflammation and oxidative stress. Key Messages: Experimental studies have shown beneficial effects of TQ against renal diseases; however, well-designed clinical trials in humans are required to confirm these effects.

Keywords:
Kidney, Inflammation, Oxidative stress, Renoprotective effects, Thymoquinone
1.
El-Tahir KE, Bakeet DM: The black seed Nigella sativa linnaeus – a mine for multi cures: a plea for urgent clinical evaluation of its volatile oil. J Taibah Univ Sci 2006; 1: 1–9.
2.
Aljabre SH, Alakloby OM, Randhawa MA: Dermatological effects of Nigella sativa. J Dermatol Dermatol Surg 2015; 19: 92–98.
3.
Randhawa MA, Al-Ghamdi MS: A review of the pharmacotherapeutic effects of Nigella sativa. Pak J Med Res 2002; 41: 77–83.
4.
Venkatachallam SK, Pattekhan H, Divakar S, Kadimi US: Chemical composition of Nigella sativa L. seed extracts obtained by supercritical carbon dioxide. J Food Sci Technol 2010; 47: 598–605.
5.
Samarghandian S, Farkhondeh T, Samini F, Borji A: Protective effects of carvacrol against oxidative stress induced by chronic stress in rat’s brain, liver, and kidney. Biochem Res Int 2016; 2016: 2645237.
6.
Samarghandian S, Farkhondeh T, Samini F, Borji A: Protective effects of carvacrol against oxidative stress induced by chronic stress in rat’s brain, liver, and kidney. Biochem Res Int 2016; 2016: 2645237.
7.
Dehkordi FR, Kamkhah AF: Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol 2008; 22: 447–452.
8.
Samarghandian S, Borji A: Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients. Pharmacognosy Res 2014; 6: 99–107.
9.
Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA: Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 2009; 11: 373–381.
10.
Samarghandian S, Azimi-Nezhad M, Farkhondeh T: Crocin attenuate tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in streptozotocin-induced diabetic rat aorta. Cytokine 2016; 88: 20–28.
11.
Al-Ghamdi M: The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol 2001; 176: 45–48.
12.
Samarghandian S, Azimi-Nezhad M, Farkhondeh T, Samini F: Anti-oxidative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney. Biomed Pharmacother 2017; 87: 223–229.
13.
Islam S, Ahsan M, Hassan CM, Malek MA: Antifungal activities of the oils of Nigella sativa seeds. Pak J Pharm Sci 1989; 2: 25–28.
14.
Morsi NM: Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol Pol 1999; 49: 63–74.
15.
Mahmoud SS, Torchilin VP: Hormetic/cytotoxic effects of Nigella sativa seed alcoholic and aqueous extracts on MCF-7 breast cancer cells alone or in combination with doxorubicin. Cell Biochem Biophys 2013; 66: 451–460.
16.
Raza M, Alghasham AA, Alorainy MS, El-Hadiyah TM: Potentiation of valproate-induced anticonvulsant response by Nigella sativa seed constituents: the role of GABA receptors. Int J Health Sci 2008; 2: 15.
17.
Kanter M, Coskun O, Budancamanak M: Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbontetrachloride-treated rats. World J Gastroenterol 2005; 11: 6684–6688.
18.
Khazdair MR: The protective effects of Nigella sativa and its constituents on induced neurotoxicity. J Toxicol 2015; 2015: 841823.
19.
Al Mofleh IA, Alhaider AA, Mossa JS, Al-Sohaibani MO, Al-Yahya MA, Rafatullah S, Shaik SA: Gastroprotective effect of an aqueous suspension of black cumin Nigella sativa on necrotizing agents-induced gastric injury in experimental animals. Saudi J Gastroenterol 2008; 14: 128.
20.
Nath KA, Norby SM: Reactive oxygen species and acute renal failure. Am J Med 2000; 109: 665–678.
21.
Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R: Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002; 39: 135–141.
22.
Ha H, Hwang IA, Park JH, Lee HB: Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 2008; 82:S42–S45.
23.
Sedeek M, Nasrallah R, Touyz RM, Hébert RL: NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol 2013; 24: 1512–1518.
24.
Erkan N, Ayranci G, Ayranci E: Antioxidant activities of rosemary (Rosmarinus officinalis L.) extract, blackseed (Nigella sativa L.) essential oil, carnosic acid, rosmarinic acid and sesamol. Food Chem 2008; 110: 76–82.
25.
Shenawy EL, Nahla S, Soliman MF, Reyad SI: The effect of antioxidant properties of aqueous garlic extract and Nigella sativa as anti-schistosomiasis agents in mice. Rev Inst Med Trop Sao Paulo 2008; 50: 29–36.
26.
Mariod AA, Ibrahim RM, Ismail M, Ismail N: Antioxidant activity and phenolic content of phenolic rich fractions obtained from black cumin (Nigella sativa) seedcake. Food Chem 2009; 116: 306–312.
27.
Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA: Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 2009; 11: 373–381.
28.
Umar S, Zargan J, Umar K, Ahmad S, Katiyar CK, Khan HA: Modulation of the oxidative stress and inflammatory cytokine response by thymoquinone in the collagen induced arthritis in Wistar rats. Chem Biol Interact 2012; 197: 40–46.
29.
Khattab MM, Nagi MN: Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytother Res 2007; 21: 410–414.
30.
Sayed AA, Morcos M: Thymoquinone decreases AGE-induced NF-κB activation in proximal tubular epithelial cells. Phytother Res 2007; 21: 898–899.
31.
Ozer EK, Goktas MT, Toker A, Pehlivan S, Bariskaner H, Ugurluoglu C, et al: Thymoquinone protects against the sepsis induced mortality, mesenteric hypoperfusion, aortic dysfunction and multiple organ damage in rats. Pharmacol Rep 2017; 69: 683–690.
32.
Faisal R, Shinwari L, Jehangir T: Comparison of the therapeutic effects of thymoquinone and methotrexate on renal injury in pristane induced arthritis in rats. J Coll Physicians Surg Pak 2015; 25: 597–601.
33.
Hosseinian S, Rad AK, Bideskan AE, Soukhtanloo M, Sadeghnia H, Shafei MN, et al: Thymoquinone ameliorates renal damage in unilateral ureteral obstruction in rats. Pharmacol Rep 2017; 69: 648–657.
34.
Wever KE, Warlé MC, Wagener FA, van der Hoorn JW, Masereeuw R, van der Vliet JA, Rongen GA: Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine. Nephrol Dial Transplant 2011; 26: 3108–3117.
35.
Grynberg K, Ozols E, Mulley W, Nikolic- Paterson DJ, Ma FY: Conditional deletion of Jnk signalling in proximal tubular epithelial cells ameliorates renal ischaemia-reperfusion injury. Nephrology 2015; 20: 18.
36.
Zhang J, Zou YR, Zhong X, Deng HD, Pu L, Peng K, et al: Erythropoietin pretreatment ameliorates renal ischaemia-reperfusion injury by activating PI3K/Akt signalling. Nephrology 2015; 20: 266–272.
37.
Huang Q, Wang Q, Zhang S, Jiang S, Zhao L, Yu L, et al: Increased hydrogen peroxide impairs angiotensin II contractions of afferent arterioles in mice after renal ischaemia-reperfusion injury. Acta Physiol 2016; 218: 136–145.
38.
Farag MM, Ahmed GO, Shehata RR, Kazem AH: Thymoquinone improves the kidney and liver changes induced by chronic cyclosporine A treatment and acute renal ischaemia/reperfusion in rats. J Pharm Pharmacol 2015; 67: 731–739.
39.
Hammad FT, Lubbad L: The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat. Int J Physiol Pathophysiol Pharmacol 2016; 8: 152.
40.
Awad AS, Kamel R, Sherief MA: Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine/spermine N-1-acetyl-transferase gene expression induced by renal ischaemia-reperfusion in rats. J Pharm Pharmacol 2011; 63: 1037–1042.
41.
Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al: Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010; 21: 556–563.
42.
Navarro-González JF, Mora-Fernández C, De Fuentes MM, García-Pérez J: Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 2011; 7: 327–340.
43.
Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, et al: Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 2013; 369: 1892–1903.
44.
Zhu W, Chen M, Shou Q, Li Y, Hu F: Biological activities of Chinese propolis and Brazilian propolis on streptozotocin-induced type 1 diabetes mellitus in rats. Evid Based Complement Alternat Med 2011; 2011: 468529.
45.
Ozawa Y, Kurihara T, Sasaki M, Ban N, Yuki K, Kubota S, et al: Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Exp Diabetes Res 2011; 2011: 108328.
46.
Luippold G, Klein T, Mark M, Grempler R: Empagliflozin. A novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus. Diabetes Obes Metab 2012; 14: 601–607.
47.
Abdelmeguid NE, Fakhoury R, Kamal SM, Al Wafai RJ: Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. J Diabetes 2010; 2: 256–266.
48.
Alimohammadi S, Hobbenaghi R, Javanbakht J, Kheradmand D, Mortezaee R, Tavakoli M, et al: Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn Pathol 2013; 8: 137.
49.
Sayed AA: Thymoquinone protects renal tubular cells against tubular injury. Cell Biochem Funct 2008; 26: 374–380.
50.
Kanter M: Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol Histol 2009; 40: 107–115.
51.
Sayed AA: Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy in rats. Eur Rev Med Pharmacol Sci 2012; 16: 808–815.
52.
Omran OM: Effects of thymoquinone on STZ-induced diabetic nephropathy: an immunohistochemical study. Ultrastruct Pathol 2014; 38: 26–33.
53.
Al-Trad B, Al-Batayneh K, El-Metwally S, Alhazimi A, Ginawi I, Alaraj M, et al: Nigella sativa oil and thymoquinone ameliorate albuminuria and renal extracellular matrix accumulation in the experimental diabetic rats. Eur Rev Med Pharmacol Sci 2016; 20: 2680–2688.
54.
Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ: New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011; 79: 33–45.
55.
Shahbazi F, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M: Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature. J Pharm Pharm Sci 2012; 15: 112–123.
56.
McWilliam SJ, Antoine DJ, Sabbisetti V, Turner MA, Farragher T, Bonventre JV, et al: Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study. PLoS One 2012; 7:e43809.
57.
Perazella MA, Moeckel GW: Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy. Semin Nephrol 2010; 30: 570–581.
58.
Maru S, Abe T, Shinohara N, Sazawa A, Maruyama S, Harabayashi T, et al: Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study. Int J Urol 2012; 19: 110–116.
59.
Cascella M, Palma G, Barbieri A, Bimonte S, Amruthraj NJ, Muzio MR, et al: Role of Nigella sativa and its constituent thymoquinone on chemotherapy-induced nephrotoxicity: evidences from experimental animal studies. Nutrients 2017; 9: 625.
60.
Elsherbiny NM, El-Sherbiny M: Thymoquinone attenuates doxorubicin-induced nephrotoxicity in rats: role of Nrf2 and NOX4. Chem Biol Interact 2014; 223: 102–108.
61.
Ali BH, Al Za’abi M, Shalaby A, Manoj P, Waly MI, Yasin J, et al: The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles. Exp Biol Med 2015; 240: 1698–1707.
62.
Jalili C, Salahshoor MR, Hoseini M, Roshankhah S, Sohrabi M, Shabanizadeh A: Protective effect of thymoquinone against morphine injuries to kidneys of mice. Iran J Kidney Dis 2017; 11: 142–150.
63.
Sayed-Ahmed MM, Nagi MN: Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats. Clin Exp Pharmacol Physiol 2007; 34: 399–405.
64.
Samarghandian S, Azimi-Nezhad M, Mehrad-Majd H, Mirhafez SR: Thymoquinone ameliorates acute renal failure in gentamicin-treated adult male rats. Pharmacology 2015; 96: 112–117.
65.
El-Sheikh AA, Morsy MA, Abdalla AM, Hamouda AH, Alhaider IA: Mechanisms of thymoquinone hepatorenal protection in methotrexate-induced toxicity in rats. Mediators Inflamm 2015; 2015: 859383.
66.
Aycan İÖ, Tokgöz O, Tüfek A, Alabalık U, Evliyaoğlu O, Turgut H, et al: The use of thymoquinone in nephrotoxicity related to acetaminophen. Int J Surg 2015; 13: 33–37.
67.
Mabrouk A, Cheikh HB: Thymoquinone ameliorates lead-induced suppression of the antioxidant system in rat kidneys. Libyan J Med 2016; 11: 310–318.
68.
Sener U, Uygur R, Aktas C, Uygur E, Erboga M, Balkas G, et al: Protective effects of thymoquinone against apoptosis and oxidative stress by arsenic in rat kidney. Ren Fail 2016; 38: 117–123.
69.
Erboga M, Kanter M, Aktas C, Sener U, Erboga ZF, Donmez YB, et al: Thymoquinone ameliorates cadmium-induced nephrotoxicity, apoptosis, and oxidative stress in rats is based on its anti-apoptotic and anti-oxidant properties. Biol Trace Elem Res 2016; 170: 165–172.
70.
Fouda AM, Daba MH, Dahab GM, Sharaf el-Din OA: Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats. Basic Clin Pharmacol Toxicol 2008; 103: 109–118.
71.
Wu P, Wang L, Wang K: Supine versus prone position in percutaneous nephrolithotomy for kidney calculi: a meta-analysis. Int J Biochem Cell Biol 2011; 43: 67–77.
72.
Okhunov Z, Friedlander JI, George AK, Duty BD, Moreira DM, Srinivasan AK, et al: STONE nephrolithometry: novel surgical classification system for kidney calculi. Urology 2013; 81: 1154–1160.
73.
Hadjzadeh MA, Mohammadian N, Rahmani Z, Behnam Rassouli F: Effect of thymoquinone on ethylene glycol-induced kidney calculi in rats. Urol J 2008; 5: 149–155.
74.
Abukhader MM: The effect of route of administration in thymoquinone toxicity in male and female rats. Indian J Pharm Sci 2012; 74: 195–200.
75.
Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA: Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad 2008; 20: 25–27.
76.
Gali-Muhtasib H, Roessner A, Schneider-Stock R: Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol 2006; 38: 1249–1253.
77.
Ramadan MF: Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L.): an overview. J Food Sci Technol 2007; 42: 1208–1218.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.